![Steven Axon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Axon
Directeur Général chez
Glycomine, Inc.
Profil
Steven Jon Axon is currently Chief Executive Officer & Director at Glycomine, Inc. since 2022.
Mr. Axon is also a Director at Metronet (UK) Ltd. since 2016.
Additionally, Mr. Axon serves as an Independent Director at Complement Therapeutics Ltd. starting in 2022.
Former roles include Chief Business Officer at Apellis Pharmaceuticals, Inc., Head-Business Development at EMD Serono, Inc. from 2005 to 2014, and Principal at Accenture LLC.
Education includes undergraduate and graduate degrees from the University of Toronto and an MBA from the International Institute for Management Development.
Postes actifs de Steven Axon
| Sociétés | Poste | Début |
|---|---|---|
Metronet (UK) Ltd.
 Metronet (UK) Ltd. Data Processing ServicesTechnology Services Provides cloud, datacenter and backup services | Directeur/Membre du Conseil | 22/03/2016 |
Complement Therapeutics Ltd.
 Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops complement medicines | Directeur/Membre du Conseil | 01/05/2022 |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Develops replacement therapies for rare genetic diseases | Directeur Général | 01/06/2022 |
Anciens postes connus de Steven Axon
| Sociétés | Poste | Fin |
|---|---|---|
Accenture LLC
 Accenture LLC Miscellaneous Commercial ServicesCommercial Services Provides financial and investment services | Corporate Officer/Principal | - |
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | - |
Formation de Steven Axon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metronet (UK) Ltd.
Metronet (UK) Ltd. Data Processing ServicesTechnology Services Provides cloud, datacenter and backup services | Technology Services |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Provides financial and investment services | Commercial Services |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Develops replacement therapies for rare genetic diseases | Health Technology |
Complement Therapeutics Ltd.
Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops complement medicines | Health Technology |
